Journal of Parkinson's Disease

Considerations for therapeutic targets for clinical trials in biomarker-characterized prodromal Parkinson's disease populations

By Ruth B. Schneider, G Skibinski, Brian K. Fiske, Tanya Simuni

ReviewInterventions

The paper

Ruth B. Schneider, G Skibinski, Brian K. Fiske, Tanya Simuni

University of Rochester; Northwestern University

Journal of Parkinson's Disease, 8 Oct 2026

doi.org/10.1177/1877718x261493297 PubMed 42847638

Neurology7 Oct 2026
More activity linked to slower Parkinson disease progression
JAMA8 Oct 2026
Nicotinamide riboside did not improve early Parkinson disease
Sleep Medicine4 Oct 2026
Dopamine loss in sleep disorder predicts Parkinson conversion